InvestorsHub Logo
Followers 24
Posts 3099
Boards Moderated 0
Alias Born 03/20/2019

Re: None

Wednesday, 04/28/2021 8:16:21 AM

Wednesday, April 28, 2021 8:16:21 AM

Post# of 402794
This is HUGE:

Brilacidin is the only non-peptidic defensin-mimetic drug candidate in the world currently in a clinical trial as a treatment for SARS-CoV-2, the coronavirus responsible for COVID-19. Additionally, Brilacidin has shown potent inhibition in vitro against different strains of coronaviruses and alphaviruses (with lab testing against other virus families also underway), supporting Brilacidin’s potential to be developed as a broad spectrum antiviral.

Too Infinity and beyond we go, we are not a DUD and we are not close to being Dunn...we have not even started yet!!!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News